View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
February 16, 2022

Innovaderm extends collaboration for TransPerfect’s Trial Interactive

Trial Interactive boosts compliance, speed and quality across site detection, selection and activation.

TransPerfect Life Sciences and the contract research organisation (CRO) Innovaderm have expanded their partnership to scale the deployment of the former’s Trial Interactive to facilitate and streamline remote clinical operations.

Innovaderm used Trial Interactive remote monitoring rooms to advance research and aid partners in discovering new treatments during the Covid-19 pandemic. 

The company allowed customers to use Trial Interactive’s Study Document Collaboration solution by integrating tailored remote monitoring rooms into its service offering, thereby facilitating successful execution of trials remotely.

Innovaderm and TransPerfect’s collaboration started with language translation services years ago.

Subsequently, Innovaderm deployed Trial Interactive’s eTMF to replace its paper-based method for document management of clinical trials.

With Innovaderm further streamlining its clinical research strategy, the organisation’s manual process to supply and collect crucial documents from sites was substituted by TI Study Start-Up.

This offered a clear pathway to activate sites and lowered timelines to commence new trials.

The platform offers document and trial management solutions that are user-friendly, aiding pharmaceutical, biotechnology companies and CROs optimise product development life cycles. 

Trial Interactive is a connected eClinical experience that boosts compliance, speed and quality across site detection, selection and activation.

Furthermore, in a secure 21 CFR Part 11-compliant environment, it delivers quick-to-implement solutions.

Innovaderm Clinical Operations director Isabel Dorion said: “Trial Interactive worked with us to ensure our remote monitoring room configuration met our key requirements so we could conduct our studies without interruptions, delays, or significant changes. 

“As we’ve faced unexpected shifts in the way we run and monitor studies, Trial Interactive has been key to enabling us to perform remote monitoring visits.”

In December 2019, TransPerfect unveiled the 10.0 version of its Trial Interactive e-clinical platform (TI10).

Related Companies

Free Whitepaper
img

Unlocking the clinical trial potential of Africa

Ongoing improvements around infrastructure, continued investment, and being home to one of the world’s largest working age populations, means that Africa’s role in the clinical trials market has transformed. In this whitepaper, Oximio outlines the dynamics of today’s clinical trial market in Africa, including the key challenges the region is facing and how sponsors can overcome them to unlock the continent’s growing potential.
by Oximio
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU